Qatar vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB
Qatar
100.0%
in 2024
Western Pacific (WHO region)
89.0%
in 2024
Qatar rank
1st
Western Pacific (WHO region) rank
2nd
New cases tested for RR-/MDR-TB over time
- Qatar
- Western Pacific (WHO region)
How they compare
Qatar currently reports 100.0% against 89.0% in Western Pacific (WHO region), a difference of 11.0%.
That makes Qatar's figure about 1.1 times Western Pacific (WHO region)'s.
The two have swapped places 8 times across 18 shared years of data; in 2005 it was Qatar ahead.
Qatar ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Qatar | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80.0% | 0.9% | 79.1% | Qatar |
| 2010s | 57.3% | 26.0% | 31.3% | Qatar |
| 2020s | 100.0% | 83.2% | 16.8% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Qatar or Western Pacific (WHO region)?
- Qatar, at 100.0% against 89.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Qatar and Western Pacific (WHO region)?
- 11.0%, with Qatar ahead.
- How many years of comparable data are there for Qatar and Western Pacific (WHO region)?
- 18 years are reported by both, from 2005 to 2024.
- How do Qatar and Western Pacific (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Qatar ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.